Page last updated: 2024-09-05

clorazepate dipotassium and enkephalin, ala(2)-mephe(4)-gly(5)-

clorazepate dipotassium has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies

Compound Research Comparison

Studies
(clorazepate dipotassium)
Trials
(clorazepate dipotassium)
Recent Studies (post-2010)
(clorazepate dipotassium)
Studies
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Trials
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-)
32590112,7271374

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barré, L; Coquerel, A; Debruyne, D; Lelong-Boulouard, V; Poisnel, G; Quentin, T1

Other Studies

1 other study(ies) available for clorazepate dipotassium and enkephalin, ala(2)-mephe(4)-gly(5)-

ArticleYear
Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain.
    Brain research, 2005, Aug-09, Volume: 1052, Issue:2

    Topics: Animals; Binding Sites; Brain; Buprenorphine; Clorazepate Dipotassium; Drug Administration Schedule; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GABA Modulators; Male; Narcotics; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Tissue Distribution; Tritium

2005